AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 0.7 |
Market Cap | 22.61M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -0.53 |
PE Ratio (ttm) | -1.42 |
Forward PE | n/a |
Analyst | n/a |
Ask | 0.81 |
Volume | 76,813 |
Avg. Volume (20D) | 78,918 |
Open | 0.76 |
Previous Close | 0.75 |
Day's Range | 0.72 - 0.76 |
52-Week Range | 0.56 - 1.34 |
Beta | undefined |
About RVP
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer...
2 months ago · businesswire.com
Retractable Technologies, Inc. Results for the Periods Ended September 30, 2024LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $10.3 million for the third quarter of 2024 and an operating loss of $5.1 million for...